A practical reference on Research chemical: what it is, how it behaves, what the literature reports, and where the honest uncertainties sit.
Reviewed 2025-11-17. Anything still debated is marked as such rather than presented as settled.
Animal and clinical reports appear mainly in Russian-language journals from the 1990s and 2000s, covering endpoints such as melatonin rhythm, lifespan in aged rodents, and retinal function. Many of these papers involve small groups, lack blinding or placebo comparison, and are difficult to retrieve through indexed databases. Review articles published in English generally summarise the claims without reanalysing the underlying data. Because no large randomised trial exists, the clinical importance of these reported effects stays unresolved and is properly described as an open question.
No national medicines regulator has approved epitalon as a therapeutic product. It is generally distributed as a research chemical, and in some jurisdictions selling peptides for human consumption without approval is restricted or prohibited. Certificates of analysis accompanying commercial material vary in which tests are performed, and independent verification of identity and purity is uncommon. Statements about anti-ageing or disease-prevention benefits on vendor pages are marketing claims rather than regulatory findings, a distinction that shapes how the compound is discussed in scientific and popular sources alike.
Epitalon is the common name for a synthetic tetrapeptide with the sequence alanine-glutamate-aspartate-glycine, usually abbreviated AEDG. All four residues are proteinogenic amino acids, and the free peptide has a calculated mass near 390 grams per mole. Because the chain is short and carries no modifications, it is assembled readily by solid-phase synthesis and is distributed mainly as a freeze-dried solid for laboratory work. Catalogue listings use the spellings epitalon, epithalone, and simply AEDG, and the three refer to the same sequence.
The compound is generally presented as a synthetic fragment of epithalamin, a pineal gland extract investigated in the former Soviet Union from the 1970s onward. Vladimir Khavinson and colleagues in Saint Petersburg developed short peptides modelled on such extracts, and epitalon became the most widely cited of those sequences. Most primary reports appeared in Russian-language journals or in proceedings with limited international circulation. Independent replication in laboratories outside that network remains sparse, and much repeated secondary material traces back to a small number of originating groups.
| Property | Value | Notes |
|---|---|---|
| Regulatory status | Not an approved drug | Marketed in most countries as a research chemical |
| Main literature language | Russian and English | Early reports concentrated in Russian journals |
| Typical stated purity | ≥95% by HPLC | Supplier declaration, seldom independently verified |
| Principal studied endpoint | Telomerase activity in vitro | Measured in cultured human cells |
| Reported administration routes | Subcutaneous, intranasal | Described in exploratory use reports |
Identity and purity are checked by reversed-phase high-performance liquid chromatography, usually with ultraviolet detection near 214 nanometres, where the peptide bond absorbs. Mass spectrometry confirms the expected mass and reveals whether truncation products or adducts are present. Acid hydrolysis followed by amino acid analysis gives the residue ratio, which should approximate one alanine, one glutamate, one aspartate and one glycine. Counter-ions such as acetate or trifluoroacetate remain in the dried product and lower net peptide content, so a stated purity figure on a label does not by itself describe how much peptide a vial holds.
Regulatory treatment differs by country. No formulation of epitalon holds a marketing authorisation as a medicine in the United States or the European Union, where material sold for laboratory use is handled as a research chemical and is not intended for human consumption. In Russia, several short peptide preparations from the same institute's peptide series are registered medicinal products, and epitalon appears in that national context. Elsewhere it is frequently offered as a cosmetic ingredient, a category with lighter requirements. Advertising claims about longevity or disease prevention are restricted in most jurisdictions, which limits how sellers describe the compound.
Freeze-dried epitalon is normally kept at minus twenty degrees Celsius in a sealed, desiccated container, protected from light. Short excursions at ambient temperature during shipping are generally tolerated, but repeated warming and cooling cycles encourage moisture uptake, which shortens shelf life. Once dissolved, the peptide is far less stable than the solid: aqueous solutions are subject to hydrolysis and to deamidation at the aspartate and glutamate residues. Working solutions are therefore held refrigerated and used within days, and repeated freezing and thawing of the same vial is best avoided.
Epitalon is a synthetic four-amino-acid peptide with the sequence alanine-glutamate-aspartate-glycine, commonly abbreviated AEDG. Its molecular formula is C14H22N4O9, and its calculated molar mass is approximately 390.35 grams per mole. The compound is a short fragment related to a peptide fraction isolated from bovine pineal gland extracts, and it is normally supplied as a lyophilised powder intended for laboratory research. It is not a registered pharmaceutical product in most countries.
The peptide emerged from research carried out in Saint Petersburg from the late 1980s onward, where investigators searched for shorter active fragments of a pineal preparation known as epithalamin. The name epitalon was chosen to reflect that parent extract. Early reports described effects on neuroendocrine markers and on the lifespan of laboratory animals. Much of that work appeared in Russian-language journals, with English translations following later, which affects how readily the original protocols can be assessed by outside groups.
Published studies on epitalon are dominated by a small number of research groups, and independent replication in other laboratories remains limited. Proposed mechanisms include activation of telomerase and modulation of melatonin rhythms, but the evidence for either rests mainly on cell cultures and animal models. Whether the peptide produces comparable effects in humans is an open question, and the absence of large controlled trials means the literature is best read as exploratory rather than settled.
The most widely cited claim is that epitalon activates telomerase and thereby extends telomere length. Supporting evidence comes largely from cultured human cells, where treatment was associated with increased telomerase activity and delayed replicative senescence. Telomerase activation is a biologically consequential effect, since the enzyme is largely silenced in most somatic cells. However, the route by which a short peptide would reach and act on the enzyme's regulatory machinery has not been established. Independent replication in human trials is scarce, so the link between cell-culture observations and whole-body aging remains an open question.
Human data are limited to small studies, often without the randomization, blinding, or control groups expected in contemporary clinical research. Reported outcomes have included changes in melatonin levels, immune markers, and subjective measures, but sample sizes were generally too small to support firm conclusions. Some reviews treat the peptide as promising while noting methodological weaknesses; others question whether the observed effects are specific. The compound is frequently discussed in longevity-focused communities, where enthusiasm often outpaces the published evidence. Separating established findings from speculation is therefore important when reading summaries of this research.
Epitalon emerged from research conducted in Saint Petersburg by Vladimir Khavinson and colleagues, who studied short peptides as potential regulators of aging. The work built on epithalamin, a pineal gland extract reported to influence neuroendocrine function. Epitalon was designed as a synthetic counterpart with a defined sequence, allowing reproducible experiments that extracts could not support. Early publications described effects on melatonin rhythms and lifespan in animal models. These findings circulated mainly in Russian-language journals during the 1990s, which limited their visibility among English-speaking researchers.
== End of the Cold War == After the end of the Revolutions of 1989, Gorbachev and President Bush Sr. met on the neutral island of Malta to discuss the events of the year, the withdrawal of the Soviet military from Eastern Europe, and the future course of their relationship. After their discussions, the two leaders publicly announced they would work together for German reunification, the normalization of relations, the resolution of Third World conflicts, and the promotion of peace and democracy (referred to by President Bush as a "New World Order"). Between the Malta Summit and the Dissolution of the Soviet Union, negotiations on several arms control pacts began, resulting in agreements such as START I and the Chemical Weapons Convention; the latter taking several years to fully implement. Additionally, the United States, still believing the Soviet Union would continue to exist in the long term, began to take steps to create a positive long-term relationship. This new relationship was demonstrated by the joint American-Soviet opposition to Iraq's invasion of Kuwait. The Soviet Union voted in the United Nations Security Council in favor of Resolution 678 authorizing the use of military force against its former Middle Eastern ally. During the late 1980s, several long-running conflicts in the developing world that had been sustained by Cold War rivalry began to wind down, including wars in Cambodia, Angola, and Nicaragua.
=== Ukraine === The Armed Forces of Ukraine's combat ration was based on a previous Russian version, consisting of commercially available cans and dried foods packed together in a sectioned box (resembles a takeout tray) made of very thin green plastic. Inside were: two 250 g mmin meal cans (boiled buckwheat groats and buckwheat w/beef); two 100 g cans of meat spread (liver pâté and beef in lard); a 160 g can of herring or mackerel; six 50 g packages small, hard crackers (resemble oyster crackers); two foil pouches (20 g each) of jam or jelly; six boiled sweets two tea bags; an envelope of instant cherry juice powder; a chicken flavour bouillon cube; two packets of sugar; and three dining packets, each with a plastic spoon, a napkin, and a moist towelette. In 2018, the Ukrainian military improved their ration contents to be more in line with NATO standards, with different menus for each day in a week. By the Russian invasion of Ukraine, according to a BBC News correspondent who received a field ration from a Ukrainian soldier, the contents of a typical Ukrainian field rations included "wheat porridge with beef; rice and meat soup; beef stew; chicken with vegetables; pork and vegetables; crackers; biscuits; tea bags; coffee; blackcurrant drink; honey; sugar; black pepper; chewing gum; bar of dark chocolate; plastic spoons; [and] moist wipes".
For South Africa and the Soviet Union—the two parties which had previously refrained from joining the US-mediated talks—the point had now been reached where the costs of continuing the war exceeded its anticipated benefits. This necessitated a change in perceptions in both nations, which began warming to the possibility of a negotiated peace. The Soviet government agreed to jointly sponsor with the US a series of renewed peace talks on 3 and 4 May 1988. For its part, South Africa made its first bid to join the tripartite negotiations and agreed to send a delegation of diplomats, intelligence chiefs, and senior SADF officers. The Soviet and US diplomats in attendance, including Crocker, made it clear to the South Africans that they wanted peace in Angola and a political settlement in South West Africa. They were also agreed on the need to bring pressure on their respective allies to bring about a solution. South Africa would be expected to comply with United Nations Security Council Resolution 435, in exchange for the complete withdrawal of Cuban troops from Angola. The Cuban and Angolan delegations had already assented to a complete Cuban withdrawal, and under US pressure produced an extremely precise timetable which extended this process over three to four years. South Africa found this unacceptable but conceded that the withdrawal could be timed to certain benchmarks in the Namibian independence process. According to Crocker, the US decision to use Security Council Resolution 435 as the basis and pivot for a regional settlement provided leverage over the discussions.
Sources: en.wikipedia.org
=== IDMS standardization effort === One problem with any creatinine-based equation for GFR is that the methods used to assay creatinine in the blood differ widely in their susceptibility to non-specific chromogens, which cause the creatinine value to be overestimated. In particular, the MDRD equation was derived using serum creatinine measurements that had this problem. The NKDEP program in the United States has attempted to solve this problem by trying to get all laboratories to calibrate their measures of creatinine to a "gold standard", which in this case is isotope dilution mass spectrometry (IDMS). In late 2009 not all labs in the U.S. had changed over to the new system. There are two forms of the MDRD equation that are available, depending on whether or not creatinine was measured by an IDMS-calibrated assay. The CKD-EPI equation is designed to be used with IDMS-calibrated serum creatinine values only.
The fruit of the plant, known as Saint Ignatius' bean, contains as many as 25 seeds embedded in the pulp. The seeds contain more strychnine than other commercial alkaloids. The properties of S. nux-vomica and S. ignatii are substantially those of the alkaloid strychnine. Strychnine was first discovered by French chemists Joseph Bienaimé Caventou and Pierre-Joseph Pelletier in 1818 in the Saint-Ignatius' bean. In some Strychnos plants a 9,10-dimethoxy derivative of strychnine, the alkaloid brucine, is also present. Brucine is not as poisonous as strychnine. Historic records indicate that preparations containing strychnine (presumably) had been used to kill dogs, cats, and birds in Europe as far back as 1640. It was allegedly used by convicted murderer William Palmer to kill his final victim, John Cook. It was also used during World War II by Oskar Dirlewanger against civilians. The structure of strychnine was first determined in 1946 by Sir Robert Robinson and in 1954 this alkaloid was synthesized in a laboratory by Robert B. Woodward. This is one of the most famous syntheses in the history of organic chemistry. Both chemists won the Nobel prize (Robinson in 1947 and Woodward in 1965). Strychnine has been used as a plot device in the author Agatha Christie's murder mysteries.
The central region of the coronal and radicular pulp contains large nerve trunks and blood vessels. This area is lined peripherally by a specialized odontogenic area which has four layers (from innermost to outermost):
=== Sexual harassment allegation === Biologist Nancy Hopkins says when she was an undergraduate in the 1960s, Crick put his hands on her breasts during a lab visit. She described the incident: "Before I could rise and shake hands, he had zoomed across the room, stood behind me, put his hands on my breasts and said, 'What are you working on?'"
Sources: en.wikipedia.org
Small studies with human participants have been reported, chiefly in Russian-language journals, but they are limited in size and design. No large randomised controlled trial with published results is available.
The most reproducible biochemical observation comes from cultured cells, where the peptide was reported to raise telomerase activity. Whether this translates into measurable health effects in animals or humans is not established.
It is offered as a research chemical for laboratory use, which places it outside the approval pathways applied to medicines. Buyers should expect documentation to differ between suppliers.
It is a four-amino-acid peptide with the sequence alanine-glutamate-aspartate-glycine. The chain is unmodified and contains only standard proteinogenic residues, which makes it straightforward to produce by solid-phase synthesis and to characterise by standard peptide methods.